Z-2071-2020 Class II Terminated

Recalled by The Binding Site Group, Ltd. — Birmingham, N/A

FDA device recall Z-2071-2020 was initiated by The Binding Site Group, Ltd. on Apr 9, 2020 and is designated Class II. Reason for recall: A software issue that may affect the analyzer's result accuracy. The recall status is terminated (terminated Aug 19, 2022). Affected quantity: 36.

Recall details

Product Type
Devices
Report Date
May 27, 2020
Initiation Date
Apr 9, 2020
Termination Date
Aug 19, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
36

Product description

The Optilite Clinical Chemistry Analyzer. IVD. Model Number: IE700. UDI-05051700017176 - Product Usage: The Optilite Clinical Chemistry Analyzer is a fully automated random access analyzer used to measure a variety of analytes that may be adaptable to the analyzer depending on the reagent used.

Reason for recall

A software issue that may affect the analyzer's result accuracy.

Distribution pattern

US Nationwide distribution including in the states of AL, AR, CA, FL, IL, IN, KS, KY, MA, MN, NC, NE, OH, PA, TX and VA.

Code information

Analyzers running with software version 7.0 or 7.01

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2071-2020
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for The Binding Site Group, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-2071-2020. Report a data issue: hello@regdatalab.com.